CROs/Service Providers

Ceri Medical acquired by Business & Decision Life Sciences

Thursday, April 24, 2014 12:54 PM

Ceri Medical, a specialist epidemiological development services company designing, running and reporting epidemiological and observational studies, has been acquired by Business & Decision Life Sciences. Headquartered in Paris, France, Ceri Medical specializes in providing strategic consulting and operational support for non-interventional studies.

More... »

WIRB Copernicus Group

Crown Bioscience, Shin Nippon Biomedical Laboratories partner

Thursday, April 24, 2014 12:51 PM

Crown Bioscience, a global drug discovery and development service company, has entered into a strategic partnership with Shin Nippon Biomedical Laboratories (SNBL), a Japan-based company engaged in the provision of preclinical and clinical drug development services for pharmaceutical companies.

More... »

CRF Health eCOA webinar series

Triclinium, Acquipharma collaborate to grow Africa’s clinical research

Thursday, April 17, 2014 11:18 AM

Triclinium Clinical Research, Africa’s largest independent niche CRO, and holding company Acquipharma, have merged to extend clinical research and development business activities in sub-Saharan Africa and other emerging markets. Under the shared umbrella of Acquipharma, Triclinium will collaborate with Cytespace Africa, a Pretoria-based site solutions organization (SSO).

More... »

Cromsource expands European headquarters, opens new office

Wednesday, April 16, 2014 01:26 PM

International CRO Cromsource has opened a new office in Verona, Italy. The building expands its European headquarters.

More... »

Arsenal Capital acquires Synchrogenix for regulatory writing, submission services, will merge it with Certara

Tuesday, April 15, 2014 01:11 PM

By Ronald Rosenberg
CenterWatch Staff Writer

Arsenal Capital Partners, a private equity firm that acquired software and scientific consulting services provider Certara last December, now has purchased Synchrogenix, an independent regulatory-writing CRO, and will merge the two.

More... »

Catalent, Zhejiang Hisun Pharma to collaborate on biosimilar development

Monday, April 14, 2014 03:05 PM

Catalent Pharma Solutions, a global provider of development solutions and advanced delivery technologies for drug, biologic and consumer health products, has signed an agreement with Zhejiang HISUN Pharmaceuticals to provide HISUN with a broad range of biosimilar cell lines, using Catalent's proprietary GPEx technology for the Chinese market. The development and manufacturing programs will benefit from the GPEx technology's proven capability to produce very stable and high-yielding cell lines.

More... »

Study: Merit increase budgets rising in global CRO industry

Friday, April 11, 2014 12:04 PM

A recent survey conducted by HR+Survey Solutions, a compensation consulting and research firm, found merit increase budgets are on the rise in the global CRO industry. The 2013-2014 CRO Industry Global Salary Planning Survey found while the highest reported salary increase budget across the globe for 2013 was 21%, that figure rose to 25% for 2014. The country with the highest average budgeted increase is Argentina, with an average increase of 16.1% for 2014. The country with the lowest average budget increase is Portugal, with an average increase budget of only 1.8%. This compares to the overall global average budgeted increase for 2014 of 4.1%.

More... »

Karyopharm Therapeutics enters agreement with Clinipace Worldwide

Thursday, April 10, 2014 01:49 PM

Clinipace Worldwide, a global digital CRO (dCRO), has announced that Karyopharm Therapeutics, a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has entered into a preferred provider agreement with Clinipace to manage several clinical programs, including oncology and wound healing.

More... »

Evotec inks agreements with Debiopharm Group, Convergence

Monday, April 7, 2014 12:37 PM

Evotec, a drug discovery alliance and development partnership company, has formed a research collaboration and licensing deal with Debiopharm Group, a Swiss-based global biopharmaceutical group, to identify and develop novel compounds having the potential to treat multiple forms of solid tumors and leukemias with defined genetic alterations.

More... »

WuXi PharmaTech invests in TruTag security platform for drug safety

Monday, April 7, 2014 12:36 PM

CRO WuXi PharmaTech, with operations in China and the U.S., and TruTag Technologies, developer of an edible, covert security platform to address the global product counterfeiting challenge, have announced that WuXi Corporate Venture Fund has made an investment in TruTag.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs